Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders

被引：33

作者：

Kiladjian, JJ ^{[1
]}

Elkassar, N

Cassinat, B

Hetet, G

Giraudier, S

Balitrand, N

Conejero, C

Briere, J

Fenaux, P

Chomienne, C

Grandchamp, B

机构：

[1] Hop Avicenne, APHP, Serv Hematol Clin, Paris, France

[2] Univ Paris 13, Paris, France

[3] Fac Med, Etab Francais Sang PL, Angers, France

[4] Fac Med, UPRES, EA3863, Angers, France

[5] Hop St Louis, APHP, Cellular Biol Unit, Paris, France

[6] Hop Bichat, INSERM, U656, F-75877 Paris, France

[7] Hop Bichat, Serv Biochim Hormonale & Genet, F-75877 Paris, France

[8] Hop Henri Mondor, APHP, Hematol Lab, F-94010 Creteil, France

来源：

LEUKEMIA | 2006年 / 20卷 / 06期

关键词：

D O I：

10.1038/sj.leu.2404214

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1181 / 1183

页数：4

共 9 条

[1] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia [J].

Antonioli, E ;

Guglielmelli, P ;

Pancrazzi, A ;

Bogani, C ;

Verrucci, M ;

Ponziani, V ;

Longo, G ;

Bosi, A ;

Vannucchi, AM .

LEUKEMIA, 2005, 19 (10) :1847-1849

[2] Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study [J].

Campbell, PJ ;

Scott, LM ;

Buck, G ;

Wheatley, K ;

East, CL ;

Marsden, JT ;

Duffy, A ;

Boyd, EM ;

Bench, AJ ;

Scott, MA ;

Vassiliou, GS ;

Milligan, DW ;

Smith, SR ;

Erber, WN ;

Bareford, D ;

Wilkins, BS ;

Reilly, JT ;

Harrison, CN ;

Green, AR .

LANCET, 2005, 366 (9501) :1945-1953

[3]

El Kassar N, 1998, CLIN CHEM, V44, P61

[4] Clonality analysis of hematopoiesis in essential thrombocythemia: Advantages of studying T lymphocytes and platelets [J].

ElKassar, N ;

Hetet, G ;

Briere, J ;

Grandchamp, B .

BLOOD, 1997, 89 (01) :128-134

[5] A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications [J].

Harrison, CN ;

Gale, RE ;

Machin, SJ ;

Linch, DC .

BLOOD, 1999, 93 (02) :417-424

[6] Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis [J].

James, C ;

Delhommeau, F ;

Marzac, C ;

Teyssandier, I ;

Le Couédic, JP ;

Giraudier, S ;

Roy, L ;

Saulnier, P ;

Lacroix, L ;

Maury, S ;

Tulliez, M ;

Vainchenker, W ;

Ugo, V ;

Casadevall, N .

LEUKEMIA, 2006, 20 (02) :350-353

[7] On the molecular origins of the chronic myeloproliferative disorders: it all makes sense [J].

Kaushansky, K .

BLOOD, 2005, 105 (11) :4187-4190

[8]

Levine RL, 2006, BLOOD

[9] USE OF RESTRICTION FRAGMENT LENGTH POLYMORPHISMS TO DETERMINE THE CLONAL ORIGIN OF HUMAN-TUMORS [J].

VOGELSTEIN, B ;

FEARON, ER ;

HAMILTON, SR ;

FEINBERG, AP .

SCIENCE, 1985, 227 (4687) :642-645

← 1 →